TCA
BIIB icon

Transcend Capital Advisors’s Biogen BIIB Stock Holding History

Transcend Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$511K Buy
2,363
+533
+29% +$102K 0.03% 440
2026
Q1 		$335K Buy
1,830
+181
+11% +$33.4K 0.03% 509
2025
Q4 		$290K Sell
1,649
-30
-2% -$4.9K 0.02% 527
2025
Q3 		$235K Buy
+1,679
New +$227K 0.02% 618
2024
Q1 		– Sell
-1,435
Closed -$371K – 536
2023
Q4 		$371K Hold
1,435
– – 0.03% 350
2023
Q3 		$369K Sell
1,435
-35
-2% -$9.36K 0.04% 342
2023
Q2 		$419K Sell
1,470
-118
-7% -$35.1K 0.04% 324
2023
Q1 		$442K Sell
1,588
-1,657
-51% -$458K 0.05% 302
2022
Q4 		$899K Sell
3,245
-600
-16% -$169K 0.1% 211
2022
Q3 		$1.03M Buy
3,845
+11
+0.3% +$2.34K 0.11% 193
2022
Q2 		$782K Buy
3,834
+1,809
+89% +$370K 0.08% 232
2022
Q1 		$426K Buy
2,025
+600
+42% +$130K 0.04% 342
2021
Q4 		$342K Buy
1,425
+38
+3% +$9.77K 0.03% 359
2021
Q3 		$376K Hold
1,387
– – 0.03% 336
2021
Q2 		$480K Buy
+1,387
New +$420K 0.07% 210
2020
Q4 		– Sell
-771
Closed -$219K – 378
2020
Q3 		$219K Buy
+771
New +$215K 0.04% 235

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Transcend Capital Advisors's BIIB Position: Q2 2026 in Review

Transcend Capital Advisors increased its Biogen (BIIB) stake by 29% in Q2 2026, buying an estimated $102K and bringing the position to 2,363 shares worth $511K. The position accounts for 0.03% of the portfolio, ranked #440.

Transcend Capital Advisors first reported a position in BIIB in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.03M in Q3 2022. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Transcend Capital Advisors held 2,363 shares of Biogen worth $511K as of Q2 2026.
  • Transcend Capital Advisors bought 533 Biogen shares in Q2 2026, an estimated $102K.
  • Biogen made up 0.03% of Transcend Capital Advisors's portfolio in Q2 2026, its #440 holding.
  • Transcend Capital Advisors first reported a position in Biogen in Q3 2020 and has held it in 16 quarters since.
  • Transcend Capital Advisors's Biogen position peaked at $1.03M in Q3 2022.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.